Clinical Trials Browser

Phase 1 × Recurrence × 3-Iodobenzylguanidine × Clear all

NCT01313936 2019-04-29

High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed Neuroblastoma

Phase 1 Completed

32 enrolled 8 charts

Neoplasms, Neuroblastoma, Recurrence